| Follow Us: Facebook Twitter



173 Parkland Plaza
Ann Arbor, MI 48103

Accuri Cytometers

Spun out of the University Of Michigan in 2002, Accuri Cytometers, Inc. is an Ann Arbor-based life sciences company that has developed revolutionary high performance cell analysis systems.

Flow cytometry systems allow medical workers to conduct complex cell analysis after the cells are suspended in fluid and passed through an optical or electronic detection device. Starting this year the company will be introducing to market their easy-to-use C6 Flow Cytometer System at a price point 75% lower than their competitors.

Needless to say, Accuri has drawn a lot of attention with its advances and was the winner of Business Review's 2007 Deal of the Year for technology.

Things look so bright for the start-up that they'll be expanding their Scio Township facility, creating 10 new jobs in the early part of 2008 with another 88 anticipated over the next five years. Currently the company employs 15.

"We are a state-supported start-up company," says CEO Jennifer Baird, "and we've been making decisions of how to manufacture our product. We've decided to do it in the state of Michigan."


Related Content

The Re-Investors

With the successful exits of Esperion and Accuri, CEO's Roger Newton and Jen Baird could have taken the money and run. Instead, they're establishing new local ventures, reinvesting in Michigan's future, and helping to grow our entrepreneurial ecosystem. read on…

Ann Arbor: Targeted For Acquisition

As Ann Arbor evolves its stable of start-ups, acquisition will be the inevitable fate for more than a few. Last month Accuri Cytometers joined the list of successful exits. But how did it happen and what does it mean for the city's entrepreneurial ecosystem? Concentrate's Jon Zemke surveys the landscape. read on…

A Mighty Wind: Q&A with Jen Baird

While the U.S. is just starting to accept that wind power can help us move toward a more sustainable future, Ann Arbor-based Accio Energy is already reinventing the technology that harnesses it. Concentrate chats with Jen Baird, the company's CEO, about Wind Power 2.0, entrepreneurship, and what's next for Michigan's new economy. read on…

Plymouth Venture Partners Fund II makes first investment, looks to reach $30M in size

Plymouth Venture Partners Fund take two is now in action, making the first investment for the Ann Arbor-based venture capital firm's second fund.Plymouth Management Company invested in Lansing-based IDV Solutions, which creates business intelligence software called Visual Fusion. It's the first investment of what Jeff Barry, partner of Plymouth Management Company, expects will be 20 deals in growth-stage companies over the next 3-4 years for this fund."We expect to do 1-2 more investments before the end of the year," Barry says.The 7-year-old VC firm now has five employees and two interns after adding a new partner over the last year. So far the firm has raised $16 million for Plymouth Venture Partners Fund II, which it expects to grow to $30 million in size. The company invests in second-stage, Michigan-based firms that are creating scalable technologies in areas like software, medical devices, or advanced manufacturing. Some of its previous investments include Accuri Cytometers, Incept BioSystems, and Janeeva.Source: Jeff Barry, partner of Plymouth Management CompanyWriter: Jon ZemkeRead more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com. read on…

InvestMichigan! VC fund pumps $96 million into Michigan companies

The InvestMichigan! Growth Capital Fund is putting up some impressive numbers these days. It has invested $95.78 million in 20 Michigan-based companies which employ 2,800 people.That list of companies reads like a who's who of promising start-ups, including Ann Arbor-based Accuri Cytometers, Salon Grafix of Auburn Hills, and InTouch Health. That last company is moving from California to Michigan, thanks in part to that investment."It's evidence that there is a vibrant, emerging economy taking shape," says Charlie Rothstein, founder and senior managing director of Beringea. The Farmington Hills-based venture capital firm, the largest in Michigan, is co-managing the InvestMichigan! Growth Capital Fund with Credit Suisse's Customized Fund Investment Group.The fund is made up of institutional investors such as the State of Michigan Retirement Systems and Municipal Employees Retirement System of Michigan. The fund invests in early stage and mature companies that are either headquartered in or moving to Michigan, or have a significant workforce in the state.So far about 46 million, or 40 percent, of the total program capital has been allocated or reserved. The fund has proven to be quite popular with local start-ups, having received applications for 846 potential investments in August alone.Source: Charlie Rothstein, founder and senior managing director of BeringeaWriter: Jon Zemke read on…
Signup for Email Alerts